Related Experiment Videos
Ascorbic acid treatment in nephropathic cystinosis in identical twins
Insights
Ascorbic acid treatment did not improve growth or chemical markers in twins with nephropathic cystinosis. Leukocyte cystine levels remained high, suggesting ascorbic acid is ineffective for reducing intracellular cystine in this condition.
Area of Science:
- Pediatric Nephrology
- Metabolic Disorders
- Clinical Pharmacology
Background:
- Nephropathic cystinosis is a rare genetic disorder characterized by lysosomal accumulation of cystine.
- Current treatments aim to manage cystine levels and prevent organ damage, but effective therapies remain limited.
Purpose of the Study:
- To evaluate the efficacy of ascorbic acid in treating nephropathic cystinosis.
- To assess the impact of ascorbic acid on leukocyte cystine content and clinical parameters in affected twins.
Main Methods:
- A 14-month double-blind study involving two HLA-identical twins with nephropathic cystinosis.
- Standard replacement therapy was administered, with one twin receiving ascorbic acid and the other a placebo.
- Leukocyte cystine content and growth parameters were monitored throughout the study.
Main Results:
- Leukocyte cystine content remained markedly elevated in both twins before, during, and after the study.
- No significant improvement in growth or chemical parameters was observed in the twin treated with ascorbic acid.
- The study did not demonstrate a reduction in intracellular cystine levels with ascorbic acid supplementation.
Conclusions:
- Ascorbic acid appears ineffective in decreasing intracellular cystine content in patients with nephropathic cystinosis.
- Further research is needed to identify more effective therapeutic strategies for managing this metabolic disorder.
Abstract:
Metabolic studies were performed on two HLA identical 9 1/2-year-old twins with nephropathic cystinosis during 14 months' participation in a double-blind study to evaluate ascorbic acid treatment for cystinosis. Replacement therapy was identical in both children throughout the study except for the use of ascorbic acid. Leukocyte cystine content was markedly abnormal and elevated in both children prior to, during, and after the ascorbic acid study. We postulate that the lack of improvement in growth or chemical parameters in the twin treated with ascorbic acid was due to the ineffectiveness of ascorbic acid in decreasing intracellular cystine content.